+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Johnson & Johnson Services, Inc. - logo

Johnson & Johnson has more than 250 companies located in 60 countries around the world. Their companies are broken down into several business segments: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson’s consumer healthcare segment produces a variety of consumer care products in the areas of baby care, skin and hair care, wound care, oral health, OTC medicines and nutritionals. Their medical devices segment produces a broad range of products used by healthcare professionals in the fields of orthopaedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics. The Janssen Pharmaceutical Companies of Johnson & Johnson are focused on oncology, immunology, neuroscience and infectious diseases, as well as cardiovascular and metabolic diseases. Their company headquarters are based in New Brunswick, New Jersey, USA.

Genital Herpes - Pipeline Review, H2 2020 - Product Thumbnail Image

Genital Herpes - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 123 Pages
  • Global
From
From
From
From
Esters Anesthetic Market - Global Forecast to 2030 - Product Thumbnail Image

Esters Anesthetic Market - Global Forecast to 2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Halothane Market - Global Forecast to 2030 - Product Thumbnail Image

Halothane Market - Global Forecast to 2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Digital Health in Immunology - Thematic Research - Product Thumbnail Image

Digital Health in Immunology - Thematic Research

  • Report
  • December 2021
  • 57 Pages
  • Global
From
Neurology Devices - Global Strategic Business Report - Product Thumbnail Image

Neurology Devices - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
From
From
From
NUT Midline Carcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

NUT Midline Carcinoma Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 383 Pages
  • Global
From
Breast Adenocarcinoma Treatment - Global Strategic Business Report - Product Thumbnail Image

Breast Adenocarcinoma Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 294 Pages
  • Global
From
From
Loading Indicator